Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.02
Delayed Data
As of Jun 26
 +0.105 / +11.48%
Today’s Change
0.86
Today|||52-Week Range
5.35
-54.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues483.0K204.0K18.0K18.0K
 
 
 
 
 
Depreciation And Amortization509.0K661.0K687.0K699.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.2M18.7M19.1M19.0M
 
 
 
 
 
Research And Development18.0M14.6M15.0M15.8M
 
 
 
 
 
Total Operating Expenses21.7M19.4M19.8M19.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.2M-19.2M-19.7M-19.7M
 
 
 
 
 
Interest Expense On Debt90.0K560.0K508.0K546.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.1M-19.5M-20.0M-20.0M
 
 
 
 
 
Income Taxes-8.0K-4.0K-5.0K-4.0K
 
 
 
 
 
Net Income-21.1M-19.5M-20.0M-20.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.8M52.8M52.9M53.0M
 
 
 
 
 
Shares To Calculate EPS Diluted52.8M52.8M52.9M53.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.37-$0.38-$0.38
 
 
 
 
 
EPS Diluted-$0.40-$0.37-$0.38-$0.38